| Bioactivity | DG013A (formate) is a phosphinic acid tripeptide mimetic inhibitor. DG013A (formate) displays significantly weak affinity for both ERAP1 (IC50=33 nM) and ERAP2 (IC50=11 nM). DG013A (formate) can be used for the research of autoimmune disease and cancer[1]. | |||||||||
| Formula | C27H37N4O4P.2/5CH2O2 | |||||||||
| Molar Mass | 530.99 | |||||||||
| Appearance | 固体 | |||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | |||||||||
| Storage |
|
|||||||||
| Reference | [1]. Birgit Wilding, et al. Investigating the phosphinic acid tripeptide mimetic DG013A as a tool compound inhibitor of the M1-aminopeptidase ERAP1. Bioorg Med Chem Lett. 2021 Jun 15;42:128050. |
DG013A formate
CAS: F: C27H37N4O4P.2/5CH2O2 W: 530.99
DG013A (formate) is a phosphinic acid tripeptide mimetic inhibitor. DG013A (formate) displays significantly weak affinit
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.